Specialty Healthcare
VERNICURA
Varenicline Tartrate Tablets 0.5 mg / 1 mg
Vernicura is a scientifically developed smoking cessation therapy formulated with Varenicline Tartrate, designed to help patients overcome nicotine addiction effectively.
Indications
- Smoking Cessation Support
- Nicotine De-addiction Therapy
- Craving & Withdrawal Symptom Reduction
Mechanism of Action
Acts as a partial agonist at α4β2 nicotinic acetylcholine receptors, reducing the rewarding effects of nicotine and managing withdrawal symptoms during cessation.
| Composition | Varenicline Tartrate Tablets |
| Dosage | As directed by Physician (Standard titration dosing) |
| Target Specialties | Psychiatry, Pulmonology, Neurology, General Medicine |
| Pack Size | Available in Alu-Alu blister pack |
| Positioning | Partner in Smoking De-addiction Therapy |
Key Benefits
- Reduces nicotine cravings significantly
- Decreases common withdrawal symptoms
- Improves smoking cessation success rate
- Helps in achieving long-term abstinence
To be used under medical supervision only.